1.12
price down icon2.61%   -0.03
after-market After Hours: 1.10 -0.02 -1.79%
loading

Citius Oncology Inc Stock (CTOR) Forecast

The Citius Oncology Inc (CTOR) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.00, representing a -100.00% decrease from the current price of $1.12. The highest analyst price target is $0.00, and the lowest is $0.00.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CTOR Price Target
Average 0.00 (-100.00% Downside)
loading

Is Citius Oncology Inc (CTOR) A Buy Now?

Oscillators
Name Value Action
RSI(14) 48.68 Neutral
STOCH(9,6) 37.73 Neutral
STOCHRSI(14) 72.53 Neutral
MACD(12,26) -0.0301 Buy
ADX(14) 8.7864 Neutral
William %R -53.85 Neutral
CCI(14) 71.74 Neutral
Buy: 1 Sell: 0 Neutral: 6
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
1.093
Buy
1.1016
Buy
MA20
1.1068
Buy
1.1171
Buy
MA50
1.1777
Sell
1.2269
Sell
MA100
1.489
Sell
1.3859
Sell
MA200
1.5767
Sell
1.4507
Sell
Buy: 4 Sell: 6 Neutral: 0
Summary: Sell
According to our latest analysis, CTOR could be considered a Neutral, with 17 technical analysis indicators signaling 5 Buy signals, 6 signaling Sell signals and 6 Neutral signals. This suggests that investors should exercise caution when entering new positions on CTOR, as the market is likely to remain volatile in the near term.
  1. RSI (Relative Strength Index): The RSI(14) value of 48.68 indicates that CTOR is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 37.73 indicates that CTOR is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 72.53 indicates that CTOR is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 8.7864 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 71.74 indicates that CTOR is still overbought but not to an extreme extent.

Citius Oncology Inc Stock (CTOR) Year by Year Forecast

drug_manufacturers_specialty_generic RDY
$13.71
price up icon 3.24%
$24.91
price up icon 2.51%
$137.37
price up icon 1.45%
drug_manufacturers_specialty_generic RGC
$30.77
price up icon 40.44%
$13.24
price up icon 1.46%
$472.06
price up icon 0.49%
Cap:     |  Volume (24h):